Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Atara Biotherapeutics, Inc. (ATRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 06/29/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 14,291 shares
@ $1.66, valued at
$23.7k
|
|
| 06/09/2023 |
3
| Henrich Jill (EVP, Global Head RA & Quality) has filed a Form 3 on Atara Biotherapeutics, Inc. |
| 06/09/2023 |
3
| Nguyen AnhCo (EVP, Chief Sci. & Tech Officer) has filed a Form 3 on Atara Biotherapeutics, Inc. |
| 06/09/2023 |
3
| Joshi Manher (EVP, Chief Medical Officer) has filed a Form 3 on Atara Biotherapeutics, Inc. |
| 06/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/02/2023 |
4
| SEIDENBERG BETH C (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| Roncarolo Maria Grazia (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| Fust Matthew K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| MALLIK AMEET (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| DOBMEIER ERIC (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 06/02/2023 |
4
| HEIDEN WILLIAM K (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 05/18/2023 |
4
| Murugan Amar (EVP, Chief Legal Officer) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 7,404 shares
@ $2.037, valued at
$15.1k
Sold 985 shares
@ $2.038, valued at
$2k
|
|
| 05/18/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 29,766 shares
@ $2.037, valued at
$60.6k
|
|
| 05/18/2023 |
4
| Banard Charlene A. (EVP, Chief Technical Officer) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 19,040 shares
@ $2.037, valued at
$38.8k
|
|
| 05/18/2023 |
4
| Hyllengren Eric J (SVP, CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 6,199 shares
@ $2.037, valued at
$12.6k
Sold 1,719 shares
@ $2.038, valued at
$3.5k
|
|
| 05/12/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/24/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/06/2023 |
4
| Touchon Pascal (President and CEO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 15,679 shares
@ $3.627, valued at
$56.9k
|
|
| 03/06/2023 |
4
| Murugan Amar (SVP, GC & Secretary) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 4,221 shares
@ $3.627, valued at
$15.3k
|
|
| 03/06/2023 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 6,871 shares
@ $3.627, valued at
$24.9k
|
|
| 03/06/2023 |
4
| Dupont Jakob (EVP, Head of R&D) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 5,074 shares
@ $3.627, valued at
$18.4k
|
|
|
|
|